L. van der Wee-Pals

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

Rutger L. van Bezooijen, Bernard A.J. Roelen, Annemieke Visser et al. · The Journal of Experimental Medicine · 2004 · 876 citations · Full text

Sclerostin, Bone Surface, Immunology +21

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

Gabri van der Pluijm, H J Vloedgraven, E. van Beek et al. · Journal of Clinical Investigation · 1996 · 306 citations · Full text

Biomedical Engineering, Orthopaedic Surgery, Osteoporosis +16

Sclerostin in Mineralized Matrices and van Buchem Disease

R.L. van Bezooijen, A.L.J.J. Bronckers, Richmond A. Th. Gortzak et al. · Journal of Dental Research · 2009 · 137 citations

Sclerostin, Pathology, Osteogenesis +20

Two Distinct Effects of Recombinant Human Tumor Necrosis Factor-a on Osteoclast Development and Subsequent Resorption of Mineralized Matrix*

Gabri van der Pluijm, W. Most, L. van der Wee-Pals et al. · Endocrinology · 1991 · 91 citations

Dietary Mannan Oligosaccharides Modulate Gut Microbiota, Increase Fecal Bile Acid Excretion, and Decrease Plasma Cholesterol and Atherosclerosis Development

Lisa R. Hoving, Saeed Katiraei, Marieke Heijink et al. · Molecular Nutrition & Food Research · 2018 · 90 citations · Full text